A study led by researchers at Weill Cornell Medicine and the New York Genome Center found that antiviral enzymes that mutate the DNA of normal and cancer cells are key promoters of early bladder cancer development.
Researchers from Cornell Tech have developed a method to identify delays in the reporting of incidents such as downed trees and power lines, which could lead to practical insights and interventions for more equitable, efficient government service.
A new preclinical model offers a unique platform for studying the Parkinson’s disease process and suggests a relatively easy method for detecting the disease.
A report from the ILR School’s Climate Justice Institute finds significant issues in New York state’s solar construction workforce, including transience, uncertain benefits and racial pay disparities.
Cornell Law School and Cornell Tech will host the General Counsel Summit, an executive education program for senior in-house attorneys and corporate leaders, on June 20 and 21, 2024, at Cornell Tech.
The fireside chat was part of a two-day visit by Dr. Robert M. Califf, commissioner of the U.S. Food and Drug Administration, who focused on medicine and health care innovations.
Krystyn J. Van Vliet has been named vice president for innovation and external engagement strategy, and Gary Koretzky ’78 will serve as interim vice provost for research.
“The Barons and the Mob: Essays on Centralized Platforms and Decentralized Crowds,” a collection co-edited by James Grimmelmann of Cornell Tech and Cornell Law School, is an introduction to the complexities of online crowds.
Weill Cornell Medicine scientists have uncovered the first evidence that astrocyte receptors can trigger opposite effects on cognitive function in male and female preclinical models.
